Effect of zoledronic acid dosing every 3 months in patients with prostate cancer with skeletal metastases: A multicenter prospective exploratory study with matched historical controls
International Journal of Urology, EarlyView.
Source: International Journal of Urology - Category: Urology & Nephrology Authors: Akihiro Yano M.D., Ph.D.
,
Yoshiaki Arai M.D.
,
Sachi Kitayama M.D.
,
Yukihiro Otsuka M.D., Ph.D.
,
Suguru Shirotake M.D., Ph.D.
,
Satoru Kawakami M.D., Ph.D. Source Type: research
More News: Cancer | Cancer & Oncology | History of Medicine | Prostate Cancer | Reclast | Study | Urology & Nephrology | Zometa